 |
The Journal of Neuroscience, January 5, 2005, 25(1):108-117; doi:10.1523/JNEUROSCI.4253-04.2005
Previous Article | Next Article 
Neurobiology of Disease
Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis
Bradley J. Turner,1,2
Julie D. Atkin,1
Manal A. Farg,1
Da Wei Zang,1
Alan Rembach,1
Elizabeth C. Lopes,1
Justin D. Patch,1
Andrew F. Hill,2,3 and
Surindar S. Cheema1
1Howard Florey Institute of Experimental Physiology and Medicine and Departments of 2Biochemistry and Molecular Biology and 3Pathology, University of Melbourne, Victoria 3010, Australia
Mutations in the intracellular metalloenzyme superoxide dismutase 1 (SOD1) are linked to neurotoxicity in familial amyotrophic lateral sclerosis (ALS) by an unclear mechanism. Golgi fragmentation and endoplasmic reticulum stress are early hallmarks of spinal motor neuron pathology in transgenic mice overexpressing mutant SOD1, suggesting that dysfunction of the neuronal secretory pathway may contribute to ALS pathogenesis. We therefore proposed that mutant SOD1 directly engages and modulates the secretory pathway based on recent evidence of SOD1 secretion in diverse human cell lines. Here, we demonstrate that a fraction of active endogenous SOD1 is secreted by NSC-34 motor neuron-like cells via a brefeldin-A (BFA)-sensitive pathway. Expression of enhanced green fluorescent protein-tagged mutant human SOD1 (hSOD1-EGFP) in NSC-34 cells induced frequent cytoplasmic inclusions and protein insolubility that correlated with toxicity. In contrast, transfection of non-neuronal COS-7 cells resulted in mutant hSOD1-EGFP cytoplasmic inclusions, oligomerization, and fragmentation without detectable toxicity. Importantly, impaired secretion of hSOD1-EGFP was common to all 10 SOD1 mutants tested relative to wild-type protein in NSC-34 cells. Treatment with BFA inhibited hSOD1-EGFP secretion with pronounced BFA-induced toxicity in mutant cells. Extracellular targeting of mutant hSOD1-EGFP via SOD3 signal peptide fusion attenuated cytoplasmic inclusion formation and toxicity. The effect of elevated extracellular SOD1 was then evaluated in a transgenic rat model of ALS. Chronic intraspinal infusion of exogenous wild-type hSOD1 significantly delayed disease progression and endpoint in transgenic SOD1G93A rats. Collectively, these results suggest novel extracellular roles for SOD1 in ALS and support a causal relationship between mutant SOD1 secretion and intraneuronal toxicity.
Key words: amyotrophic lateral sclerosis; CSF; neuronal inclusion; NSC-34 cell; protein aggregation; secretion; superoxide dismutase 1; transgenic rat
Received Oct 13, 2004;
revised November 11, 2004;
accepted November 11, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
A. K. Walker, M. A. Farg, C. R. Bye, C. A. McLean, M. K. Horne, and J. D. Atkin
Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis
Brain,
November 10, 2009;
(2009)
awp267v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Veeranki, B. Kim, and L. Kim
The GPI-anchored superoxide dismutase SodC is essential for regulating basal Ras activity and for chemotaxis of Dictyostelium discoideum
J. Cell Sci.,
September 15, 2008;
121(18):
3099 - 3108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urushitani, S. A. Ezzi, A. Matsuo, I. Tooyama, and J.-P. Julien
The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS
FASEB J,
July 1, 2008;
22(7):
2476 - 2487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kang and S. Rivest
MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis
J. Cell Biol.,
December 17, 2007;
179(6):
1219 - 1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Fernandez, S. Fernandez, P. Carrero, M. Garcia-Garcia, and I. Torres-Aleman
Calcineurin in Reactive Astrocytes Plays a Key Role in the Interplay between Proinflammatory and Anti-Inflammatory Signals
J. Neurosci.,
August 15, 2007;
27(33):
8745 - 8756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Urushitani, S. A. Ezzi, and J.-P. Julien
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis
PNAS,
February 13, 2007;
104(7):
2495 - 2500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Atkin, M. A. Farg, B. J. Turner, D. Tomas, J. A. Lysaght, J. Nunan, A. Rembach, P. Nagley, P. M. Beart, S. S. Cheema, et al.
Induction of the Unfolded Protein Response in Familial Amyotrophic Lateral Sclerosis and Association of Protein-disulfide Isomerase with Superoxide Dismutase 1
J. Biol. Chem.,
October 6, 2006;
281(40):
30152 - 30165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kikuchi, G. Almer, S. Yamashita, C. Guegan, M. Nagai, Z. Xu, A. A. Sosunov, G. M. McKhann II, and S. Przedborski
Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model
PNAS,
April 11, 2006;
103(15):
6025 - 6030.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|